Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Primary Care

Understanding Your Diagnosis: Distal 16p11.2 Microdeletion syndrome (BP2-BP3)

At a Glance

A distal 16p11.2 BP2-BP3 microdeletion is a small missing section of chromosome 16 that differs from the more common BP4-BP5 deletion. Its effects vary widely, but monitoring weight, blood sugar, development, behavior, and seizures can guide personalized care.

Receiving a diagnosis of Distal 16p11.2 Microdeletion syndrome can feel overwhelming, especially since many doctors may not have encountered this specific genetic variation before [1]. It is natural to feel confused or even a bit lost as you search for answers. This page is designed to help you understand exactly what this diagnosis means, how it differs from other similar-sounding conditions, and what it might look like for you or your child.

Understanding the “Distal” Difference

Chromosomes are like long instruction manuals for the body, and a microdeletion means a small piece of one of those manuals is missing. The 16p11.2 region of chromosome 16 is complex because it contains several “breakpoints” (labeled BP1 through BP5) where deletions can occur.

The most important thing to know is that your diagnosis—the Distal BP2-BP3 deletion—is distinct from the more commonly discussed “proximal” or “typical” BP4-BP5 deletion [2][3].

Feature Distal Deletion (BP2-BP3) Proximal Deletion (BP4-BP5)
Size Approximately 220–244 kb [2][4] Approximately 600 kb [2][3]
Genes Involved Typically 9 genes, including SH2B1 and LAT [2][4] Approximately 25-30 genes, including KCTD13 and MAPK3 [2][3]
Reported Features Highly variable. Often includes severe obesity risk and metabolic issues (like insulin resistance) [5][2], along with variable neurodevelopmental traits (ASD, ADHD). Highly variable. Often includes intellectual disability, speech delay, ASD, and risk of seizures [6][7], as well as weight differences.

Because these two deletions involve different genes, the information you find online about “16p11.2 deletion” may not always apply to you. Always look for the terms Distal or BP2-BP3 to ensure you are reading the most relevant information [2].

The Role of Specific Genes

In the BP2-BP3 region, two genes are frequently studied because of their potential impact on health:

  • SH2B1: This gene is a key contributor to how the body manages energy. It helps control leptin and insulin signaling, which are hormones that tell your brain when you are full and help your body process sugar [5][8]. When this gene is missing, it can increase the risk of early-onset obesity and type 2 diabetes [5].
  • LAT: Research suggests this candidate gene may be involved in brain development. In some preliminary studies, changes in the dosage of this gene have been linked to differences in head size (microcephaly or macrocephaly) and neurodevelopmental outcomes, though this is not fully settled clinical causation [3].

Why Symptoms Vary: “Variable Expressivity”

One of the most challenging aspects of this syndrome is its variable expressivity. This means that even though the same genetic piece is missing, the symptoms can look very different from one person to another—even within the same family [9][10].

Commonly reported features include:

  • Weight and Metabolism: Obesity is a frequent finding, reported in about 74% of individuals in one study cohort [2]. However, some people with the exact same deletion may have a low BMI [10]. Carriers may also develop type 2 diabetes earlier in life than others [5].
  • Neurodevelopment: Some individuals may have Autism Spectrum Disorder (ASD), attention issues (like ADHD), or difficulties with motor coordination [11][10]. Others may have only mild learning challenges or no significant neurological symptoms at all [9].
  • Seizures: Seizures have been reported in about 9% of some distal cohorts, though the rate is closer to 20% in the broader 16p11.2 population [12][13]. Any suspected seizure requires a thorough medical evaluation.

Inheritance and Family

A distal 16p11.2 deletion can happen in two ways:

  1. De Novo: This means the deletion occurred by chance for the first time in the patient and was not inherited from a parent [14].
  2. Inherited: The deletion was passed down from a parent. Because of the variable expressivity mentioned above, a parent might have the deletion but only experience very mild traits—such as a lifelong struggle with weight or minor attention issues—while their child may be more significantly affected [10][9]. A parent carrying the deletion has a 50% chance of passing it to each pregnancy.

Testing parents can help clarify the inheritance pattern, though it cannot predict exactly how the syndrome will progress for an individual [10].

Navigating Your Care

Because this condition is rare, your primary care doctor will likely serve as the “medical home” to coordinate your care [1]. Depending on your specific symptoms, your team may include:

  • Endocrinologists to monitor growth, weight, and blood sugar [5].
  • Developmental Pediatricians or Neurologists to evaluate learning, behavior, or seizure activity [2][13].
  • Physical or Occupational Therapists to support motor skills and daily functioning [15].

While a diagnosis can be shocking, it is also a tool. It provides a roadmap for monitoring and early intervention, helping you and your medical team stay ahead of potential health challenges [1][15].

Common questions in this guide

What is distal 16p11.2 BP2-BP3 microdeletion syndrome?
It is a genetic condition in which a small section of chromosome 16, between breakpoints BP2 and BP3, is missing. It is different from the more common proximal BP4-BP5 deletion, and its effects can range from mild to more significant health or developmental differences.
How does the distal BP2-BP3 deletion differ from the proximal 16p11.2 deletion?
The distal deletion is usually smaller, about 220–244 kilobases, and typically includes genes such as SH2B1 and LAT. The proximal BP4-BP5 deletion is usually about 600 kilobases and includes a different group of genes, so information about one deletion may not apply to the other.
Can a distal 16p11.2 deletion cause obesity or diabetes?
Loss of SH2B1 can increase the risk of early-onset obesity, insulin resistance, and type 2 diabetes because the gene helps with leptin and insulin signaling. Not everyone with the deletion develops these problems, so monitoring growth, weight, and blood sugar can help guide care.
Why can the same 16p11.2 deletion affect relatives differently?
The condition has variable expressivity, meaning people with the same deletion can have different features and levels of impact. One family member may have mild weight or attention concerns while another has more substantial metabolic, developmental, or neurological needs.
Can distal 16p11.2 BP2-BP3 deletion syndrome be inherited?
Yes. The deletion may occur for the first time in a person, called de novo, or it may be inherited from a parent who has mild or unrecognized features. If a parent carries the deletion, there is a 50% chance of passing it to each pregnancy, although parent testing cannot predict how severely an individual will be affected.
What kind of medical care may be needed for this deletion?
Primary care can coordinate monitoring and referrals based on the person's features. Endocrinology may help with weight and blood sugar, developmental pediatrics or neurology may assess development, behavior, or seizures, and physical or occupational therapy may support movement and daily skills.

Get notified when new evidence is published on Distal 16p11.2 microdeletion syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Health supervision for children and adolescents with 16p11.2 deletion syndrome.

    Chung WK, Herrera FF,

    Cold Spring Harbor molecular case studies 2023; (9(4)) doi:10.1101/mcs.a006316.

    PMID: 38050025
  2. 2

    Evaluation of 100 Dutch cases with 16p11.2 deletion and duplication syndromes; from clinical manifestations towards personalized treatment options.

    Vos N, Kleinendorst L, van der Laan L, et al.

    European journal of human genetics : EJHG 2024; (32(11)):1387-1401 doi:10.1038/s41431-024-01601-2.

    PMID: 38605127
  3. 3

    The Immune Signaling Adaptor LAT Contributes to the Neuroanatomical Phenotype of 16p11.2 BP2-BP3 CNVs.

    Loviglio MN, Arbogast T, Jønch AE, et al.

    American journal of human genetics 2017; (101(4)):564-577 doi:10.1016/j.ajhg.2017.08.016.

    PMID: 28965845
  4. 4

    Discordant phenotypes in monozygotic twins with 16p11.2 microdeletions including the SH2B1 gene.

    Li L, Huang L, Lin S, et al.

    American journal of medical genetics. Part A 2017; (173(8)):2284-2288 doi:10.1002/ajmg.a.38284.

    PMID: 28544142
  5. 5

    Chromosomal deletions on 16p11.2 encompassing SH2B1 are associated with accelerated metabolic disease.

    Hanssen R, Auwerx C, Jõeloo M, et al.

    Cell reports. Medicine 2023; (4(8)):101155 doi:10.1016/j.xcrm.2023.101155.

    PMID: 37586323
  6. 6

    16p11.2 deletion syndrome.

    Chung WK, Roberts TP, Sherr EH, et al.

    Current opinion in genetics & development 2021; (68()):49-56 doi:10.1016/j.gde.2021.01.011.

    PMID: 33667823
  7. 7

    TBX6 null variants and a common hypomorphic allele in congenital scoliosis.

    Wu N, Ming X, Xiao J, et al.

    The New England journal of medicine 2015; (372(4)):341-50 doi:10.1056/NEJMoa1406829.

    PMID: 25564734
  8. 8

    Genetic and structural variation in the SH2B1 gene in the Belgian population.

    Aerts E, Beckers S, Zegers D, et al.

    Molecular genetics and metabolism 2015; (115(4)):193-8.

    PMID: 26031769
  9. 9

    The Phenotypic Spectrum of 16p11.2 Recurrent Chromosomal Rearrangements.

    Mitrakos AK, Kosma K, Makrythanasis P, Tzetis M

    Genes 2024; (15(8)) doi:10.3390/genes15081053.

    PMID: 39202413
  10. 10

    The Phenotypic variability of 16p11.2 distal BP2-BP3 deletion in a transgenerational family and in neurodevelopmentally ascertained samples.

    Woodbury-Smith M, D'Abate L, Stavropoulos DJ, et al.

    Journal of medical genetics 2023; (60(12)):1153-1160 doi:10.1136/jmg-2022-108818.

    PMID: 37290907
  11. 11

    Chromosomal contacts connect loci associated with autism, BMI and head circumference phenotypes.

    Loviglio MN, Leleu M, Männik K, et al.

    Molecular psychiatry 2017; (22(6)):836-849 doi:10.1038/mp.2016.84.

    PMID: 27240531
  12. 12

    PRRT2-related phenotypes in patients with a 16p11.2 deletion.

    Vlaskamp DRM, Callenbach PMC, Rump P, et al.

    European journal of medical genetics 2019; (62(4)):265-269 doi:10.1016/j.ejmg.2018.08.002.

    PMID: 30125676
  13. 13

    PRRT 2-Related Epilepsy: From Self-Limited Infantile Epilepsy to Atypical Epilepsy Phenotypes.

    Komar M, Sidhu J, Joseph J, et al.

    Neurology. Genetics 2025; (11(3)):e200267 doi:10.1212/NXG.0000000000200267.

    PMID: 40401013
  14. 14

    [Prenatal ultrasound and genetic characteristics of 60 fetuses with 16p11.2 microdeletion].

    Pan L, Wu J, Duan S, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2026; (51(4)):737-743 doi:10.11817/j.issn.1672-7347.2026.260007.

    PMID: 42394496
  15. 15

    Developmental presentation, medical complexities, and service delivery for a child with 16p11.2 deletion syndrome.

    Bamonte L

    Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association 2015; (27(1)):90-9 doi:10.1097/PEP.0000000000000105.

    PMID: 25521272

This page explains a distal 16p11.2 BP2-BP3 diagnosis for informational purposes only and does not constitute medical advice. Your healthcare team should interpret the specific genetic report and tailor monitoring and support for you or your child.